Looking for a specific product?

Make a search for products & suppliers, articles & news.

Collaboration across the pond develops a new living skin equivalent testing model

Epistem and ScandiDerma announced today that they aim to develop a new in vitro human living skin equivalent model for testing inflammatory responses.

Facts

Innovation Norway is the Norwegian Government's most important instrument for innovation and development of Norwegian enterprises and industry. Innovation Norway support companies in developing their competitive advantage and to enhance innovation. Norwegian enterprises have access to a broad business support system as well as financial means. By combining local industry knowledge and international networks with the business ideas and the motivation of entrepreneurs, the foundation for new successful businesses is created. For more information visit www.innovationnorway.com.

Technology Strategy Board is the UK's innovation agency and works to create economic growth by ensuring that the UK is a global leader in innovation. Sponsored by the Department for Business, Innovation and Skills (BIS), the Technology Strategy Board brings together business, research and the public sector, supporting and accelerating the development of innovative products and services to meet market needs, tackle major societal challenges and help build the future economy. For more information please visit www.innovateuk.org.

This is a novel method that will add to the field of dermatological testing as a whole and help create more activity in extracting high value compounds from biomass. The project will last from May 2013 to March 2014 and will run from the project leader Epistem's facilities in Manchester UK and ScandiDerma's facilities in Barents Biocenter, Tromsø, Norway.

"The collaboration with ScandiDerma presents an exciting opportunity to leverage Epistem's strong scientific background in skin biology and inflammation to address the shortage of robust human dermatology models for testing inflammatory responses" said Matthew Walls, Epistem CEO. 

"For ScandiDerma this is an important milestone in building up our competence around test-systems and how to rapidly determine good lead candidates from our bioprospecting activities" noted Ingebjørg Pernille Nedal, CEO ScandiDerma.

The collaboration is made possible through the UK's innovation agency, the Technology Strategy Board, and Innovation Norway following a successful application for funding in the "Sustainable high value chemical manufacture through industrial biotechnology" competition.

(Source: Marketwire)

Associated companies:


Related news

Latest news

Resolutuions at Semcon's annual general meeting 2017

Semcon’s Annual General Meeting (AGM) was held on Wednesday April 26,

DNV GL launches new PSC Planner application

Classification society DNV GL has launched a new application on its My DNV GL portal

300 solutions that will change the world

Global Opportunity Explorer launch

Wind powered oil recovery concept moves closer to implementation

The DNV GL-led joint industry project,

Feeding the future with AKVA

AKVA group has seen a strong market response to the new AKVAconnect feeding system, released late 2016 into the Chilean market. Customer feedback has been very positive resulting in a strong increase in sales.

The Mohammed bin Rashid Al Maktoum Solar Park Phase II will be managed by GreenPowerMonitor monitoring solutions

The project forms part of the larger 1 GW Mohammed bin Rashid Al Maktoum Solar Park

Chalet and chaletino, oak flooring of exceptional length and width

Chalet and Chaletino from BOEN is parquet flooring made with exceptionally wide and long planks of the finest timber.

Fire in Vestdavit offices – Possible disruption of service

Vestdavit and all staff would like to express sincere thanks for the inquiries and good wishes sent to us by our industry partners,

TechnipFMC and DOF Subsea announce delivery of Sk

Technip FMC and DOF Subsea announce the delivery of Skandi Búzios and commencement of contract with Petrobras.